RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Orosol for the treatment of radio and chemotherapy-induced oral mucositis
The first topical protease inhibitor with antibacterial properties discovered and patented by Vitro-Bio. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Aug 2011 - 65 pages - $2,000
Oral Mucositis - Pipeline Review, Q1 2011
Mar 2011 - 45 pages - $500
Mucositis - Pipeline Review, Q1 2011
Mar 2011 - 57 pages - $500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
Apr 2011 - 137 pages - $3,500
Oral Mucositis - Pipeline Review, H2 2011
Oct 2011 - 80 pages - $500
Mucositis Therapy Area Pipeline Report
Sep 2010 - 53 pages - $1,495
Mucositis - Pipeline Review, H2 2011
Oct 2011 - 49 pages - $500
Mucositis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 59 pages - $1,000
Chemotherapy Induced Anemia - Pipeline Review, H2 2011
Oct 2011 - 49 pages - $500
Radiation Therapy Oncology Group – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Oral Health del
Mucositis, Radiation-induced del
Development phase
Phase I/II del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us